Actionable news
0
All posts from Actionable news
Actionable news in INFN: Infinera Corporation,

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Stocks were up yet again on Friday, making for one serious move, with the Dow up about 1,000 points from the lows of just last Friday. Investors have proven over and over that they will buy the top stocks on weakness. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week. The goal is to find new investing and trading ideas for our readers. Some of these analyst calls cover stocks to buy. Others cover stocks to sell or avoid. These are this Friday’s top analyst upgrades, downgrades and initiations.

AT&T Inc. (NYSE: T) was maintained as Hold with a $35 price target at Canaccord Genuity. The firm’s comments were mostly positive, but it remains unprepared to call for a turn in growth yet, so it held the rating firm.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) was down almost 18% on Thursday after what was supposed to be a positive drug trial. Bank of America Merrill Lynch lowered its rating to Neutral from Buy and cut the price objective to $12 from $16 (versus a $9.75 prior close).

Eli Lilly & Co. (NYSE: LLY) was raised to Outperform from Neutral and the price target was raised to $105 from a prior target of $89 (versus an $83.77 close) at Credit Suisse.

Facebook Inc. (NASDAQ: FB) was reiterated as Outperform at Credit Suisse, and the firm raised its price target to $115 from $110, with raised estimates, after adding more revenue generation. Facebook closed at $92.46 and has a consensus analyst price target of $111.60.

Flextronics International Ltd. (NASDAQ: FLEX) was started as Buy with a $14.00 price target (versus a...


More